ICD-10-CM Billable Code

T39.1X5

Adverse effect of 4-Aminophenol derivatives

Clinical Classification Guidelines

Medical Intelligence & Overview

The ICD-10 code T39.1X5 pertains to adverse effects caused by 4-Aminophenol derivatives. These substances are a class of medications often used for pain relief and fever reduction. While generally safe when used appropriately, some individuals may experience unwanted side effects or adverse reactions. Recognizing these reactions can help ensure prompt medical attention and management.

Causes & Symptoms

Clinical Causes: Excessive or prolonged use of medications containing 4-Aminophenol derivatives, such as acetaminophen (paracetamol). Taking higher-than-recommended doses of pain relievers or fever reducers. Combining multiple medications that contain 4-Aminophenol derivatives without medical supervision. Individuals with impaired liver function or pre-existing liver conditions.

Key Symptoms: Nausea and vomiting Loss of appetite Stomach pain or discomfort Jaundice (yellowing of the skin and eyes) Dark urine Fatigue or weakness Allergic reactions like rash, itching, or swelling Signs of liver damage, such as elevated liver enzymes in blood tests

Diagnostic & Treatment

Diagnosis Path: Diagnosis primarily relies on clinical history and recognition of symptoms following the use of medications containing 4-Aminophenol derivatives. Blood tests may be performed to assess liver function and detect any signs of liver damage. Healthcare providers might also review medication history to identify potential causative agents.

Treatment Protocols: Treatment focuses on managing adverse effects and preventing further damage. Supportive care may include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T39.1X5 a billable ICD-10 code?
Yes, T39.1X5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T39.1X5?
Clinical documentation must specify the nature of Adverse effect of 4-Aminophenol derivatives and any associated comorbidities for accurate reporting.

Cite this Clinical Reference